Cassava Sciences stock holds at USD 1.54 as cash remains central

Published on 09/22/2026 at 07:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cassava Sciences stock traded at USD 1.54 on September 21, 2026, with a market value of USD 34.6 million. Cash levels remain key.

SAVA, US14428V1035, Illustration mit AI erstellt.

Cassava Sciences stock (ISIN US14428V1035) closed at USD 1.54 on September 21, 2026, on Nasdaq, according to the latest completed-session market data. The company remains a closely watched biotechnology name, with its small market value making operating figures and financing capacity especially important for investors.

Market value remains limited

The September 21, 2026 closing price of USD 1.54 gives Cassava Sciences an equity value of USD 34.6 million. That valuation is materially smaller than the cash balance reported for the latest available reporting period, a comparison that places liquidity rather than sales growth at the center of the investment case.

The shares traded within a 52-week range of USD 1.20 to USD 8.50 as of September 21, 2026. The USD 7.00 spread between the yearly low and high underlines the stock's elevated historical volatility, while the latest close remained USD 6.96 below the top of that range.

Cash flow defines the story

For the latest reported quarter available by September 22, 2026, Cassava Sciences recorded no meaningful commercial revenue and continued to operate as a development-stage biotechnology company. Its financial profile therefore differs from that of established pharmaceutical businesses, because clinical progress and funding determine the path to future value.

In the latest reported period, the company also posted a net loss and continued to consume cash through research and development and administrative expenses. Those figures make the cash runway a more relevant operating measure than revenue, and they increase the importance of any future clinical, regulatory or financing update.

USD 1.54 sets the reference point

Cassava Sciences stock closed at USD 1.54 on Nasdaq on September 21, 2026. The price is USD 0.34 above the 52-week low of USD 1.20 and USD 6.96 below the 52-week high of USD 8.50, providing the latest dated reference point for the company.